HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distinctive renal cell tumor simulating atrophic kidney with 2 types of microcalcifications. Report of 3 cases.

Abstract
We report 3 cases of primary renal cell tumor simulating atrophic kidney with distinct gross, morphologic, immunohistochemical, and molecular genetic features. The tumors were retrieved out of more than 17 000 renal tumors from the Plzen Tumor Registry. Tissues for light microscopy had been fixed, embedded, and stained with hematoxylin and eosin using routine procedures. The tumors were further analyzed using immunohistochemistry, array comparative genomic hybridization, and human androgen receptor. Analyses of VHL gene and loss of heterozygosity (LOH) 3p were also performed. The patients were 2 women and 1 man, with ages ranging from 29 to 35 years (mean, 31.3 years). Grossly, the neoplasms were encapsulated and round with largest diameter of 3.5 cm (mean, 3.2 cm). Follow-up available for all patients ranged from 2 to 14 years (mean, 8 years). No aggressive behavior was noted. Histologically, akin to atrophic (postpyelonephritic) kidney parenchyma, the tumors were composed of follicles of varying sizes that were filled by eosinophilic secretion. Rare areas contained collapsed follicles. Each follicle was endowed with a small capillary. The stroma was loose, inconspicuous, and focally fibrotic. Two types of calcifications were noted: typical psammoma bodies and amorphous dark-blue stained calcified deposits. Immunohistochemically, tumors were strongly positive for cytokeratins (OSCAR), CD10, and vimentin, with weak immunopositivity for CAM5.2 and AE1-AE3. WT1 and cathepsin K were weakly to moderately focally to diffusely positive. Tumors were negative for cytokeratin 20, carbonic anhydrase IX, parvalbumin, HMB45, TTF1, TFE3, chromogranin A, thyroglobulin, PAX8, and ALK. Only 1 case was suitable for molecular genetic analyses. No mutations were found in the VHL gene; no methylation of VHL promoter was noted. No numerical aberrations were found by array comparative genomic hybridization analysis. LOH for chromosome 3p was not detected. Analysis of clonality (human androgen receptor) revealed the monoclonal nature of the tumor. We describe an unknown tumor of the kidney that (1) resembles renal atrophic kidney or nodular goiter of thyroidal gland; (2) contains a leiomyomatous capsule and 2 types of calcifications; (3) lacks mitoses, atypias, necroses, and hemorrhages and nearly lack Ki-67 positivity; and (4) so far showed benign biological behavior.
AuthorsOndrej Hes, Tulio Geraldo de Souza, Kristyna Pivovarcikova, Petr Grossmann, Petr Martinek, Naoto Kuroda, Denisa Kacerovska, Marian Svajdler, Lubomir Straka, Fredrik Petersson, Milan Hora, Michal Michal
JournalAnnals of diagnostic pathology (Ann Diagn Pathol) Vol. 18 Issue 2 Pg. 82-8 (Apr 2014) ISSN: 1532-8198 [Electronic] United States
PMID24456861 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • AR protein, human
  • Biomarkers, Tumor
  • Receptors, Androgen
  • Vimentin
  • Keratins
  • Von Hippel-Lindau Tumor Suppressor Protein
  • VHL protein, human
Topics
  • Adult
  • Atrophy (pathology)
  • Biomarkers, Tumor (metabolism)
  • Calcinosis
  • Comparative Genomic Hybridization
  • DNA Methylation
  • Diagnosis, Differential
  • Female
  • Goiter, Nodular (pathology)
  • Humans
  • Keratins (metabolism)
  • Kidney (pathology)
  • Kidney Neoplasms (diagnosis, genetics, pathology)
  • Leiomyomatosis (diagnosis, genetics, pathology)
  • Loss of Heterozygosity
  • Male
  • Mutation
  • Receptors, Androgen (genetics, metabolism)
  • Thyroid Gland (pathology)
  • Vimentin (metabolism)
  • Von Hippel-Lindau Tumor Suppressor Protein (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: